Medical - Diagnostics/Research Stocks
The companies in this industry provide analysis and diagnostic services by examining body fluids and producing images of the body for medical professionals and patients. Demand correlates with the number of people receiving medical treatment. The profitability of individual companies depends on efficient operations and take advantage of the ability to draw business from a wide geographical area.
Share This Page
B
Industry Rank
This industry ranks #27 out of 123 stock categories.
B
Average POWR Rating
The average market cap-weighted POWR Rating for stocks in this industry is B (Buy).
| Rk | Symbol | Name | Last | Open | High | Low | 52WK Hi | 52WK Lo | Day Chg | YTD Chg | 12M Chg | Mkt Cap | 50D MA | ± 50D | 200D MA | ± 200D | POWR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc | 385.66 | 362.05 | 386.57 | 362.00 | 386.57 | 250.21 | 25.89 (7.20%) | 18.88% | 28.01% | 152.32B | 343.08 | 12.41% | 316.65 | 21.79% |
A Strong Buy |
| 2 | A | Agilent Technologies, Inc. | 90.28 | 88.83 | 90.64 | 88.55 | 93.04 | 61.13 | 2.17 (2.46%) | 6.32% | 19.46% | 27.88B | 83.96 | 7.52% | 79.89 | 13.01% |
A Strong Buy |
| 3 | QDEL | Quidel Corporation | 235.15 | 227.50 | 236.17 | 226.80 | 236.17 | 52.49 | 8.11 (3.57%) | 213.41% | 300.87% | 9.88B | 175.91 | 33.67% | 100.16 | 134.77% |
A Strong Buy |
| 4 | QGEN | Qiagen N.V. Common Shares | 43.15 | 43.25 | 43.52 | 43.15 | 44.41 | 25.04 | 0.64 (1.51%) | 27.66% | 7.68% | 9.83B | 42.79 | 0.85% | 37.86 | 13.98% |
A Strong Buy |
| 5 | ICLR | ICON plc - Ordinary Shares | 170.18 | 169.00 | 171.18 | 167.95 | 178.99 | 104.28 | 3.27 (1.96%) | -1.19% | 10.59% | 9.13B | 160.62 | 5.95% | 157.10 | 8.33% |
A Strong Buy |
| 6 | CRL | Charles River Laboratories International, Inc. | 181.31 | 177.00 | 181.98 | 174.82 | 189.85 | 95.58 | 5.75 (3.28%) | 18.69% | 27.55% | 8.97B | 167.56 | 8.21% | 148.95 | 21.72% |
A Strong Buy |
| 7 | NEOG | Neogen Corporation | 79.50 | 79.50 | 79.90 | 78.08 | 79.90 | 48.91 | 1.57 (2.01%) | 21.82% | 29.07% | 4.19B | 69.10 | 15.05% | 66.64 | 19.30% |
A Strong Buy |
| 8 | NVTA | Invitae Corporation | 33.44 | 30.86 | 33.81 | 30.52 | 33.81 | 7.41 | 2.96 (9.71%) | 107.32% | 39.22% | 4.18B | 19.10 | 75.11% | 18.04 | 85.37% |
A Strong Buy |
| 9 | NTRA | Natera, Inc. | 46.68 | 48.36 | 48.58 | 46.60 | 50.57 | 16.87 | -1.40 (-2.91%) | 38.56% | 77.85% | 3.67B | 43.12 | 8.26% | 36.80 | 26.86% |
A Strong Buy |
| 10 | NEO | NeoGenomics, Inc. | 34.63 | 34.50 | 35.03 | 34.01 | 35.03 | 18.52 | 0.75 (2.21%) | 18.39% | 49.66% | 3.65B | 28.12 | 23.15% | 26.90 | 28.75% |
A Strong Buy |
| 11 | VIVO | Meridian Bioscience Inc. | 23.99 | 24.23 | 24.88 | 23.81 | 24.94 | 5.51 | 0.20 (0.84%) | 145.55% | 100.84% | 1.03B | 16.29 | 47.27% | 10.85 | 121.10% |
A Strong Buy |
| 12 | HBIO | Harvard Bioscience, Inc. | 3.74 | 3.77 | 3.77 | 3.64 | 3.77 | 1.39 | 0.11 (3.03%) | 22.62% | 98.16% | 143.54M | 2.79 | 33.83% | 2.79 | 34.09% |
A Strong Buy |
| 13 | DGX | Quest Diagnostics Incorporated | 118.24 | 114.95 | 118.80 | 114.40 | 125.00 | 73.02 | 4.19 (3.67%) | 12.13% | 14.63% | 15.81B | 112.04 | 5.53% | 104.03 | 13.66% |
B Buy |
| 14 | BIO | Bio-Rad Laboratories, Inc. | 470.14 | 460.60 | 470.28 | 460.60 | 497.42 | 303.82 | 11.78 (2.57%) | 27.05% | 49.54% | 13.94B | 455.69 | 3.17% | 385.65 | 21.91% |
B Buy |
| 15 | CDNA | CareDx, Inc. | 34.21 | 34.93 | 34.99 | 34.01 | 41.27 | 13.04 | -0.46 (-1.33%) | 58.60% | -3.28% | 1.52B | 30.78 | 11.15% | 24.63 | 38.88% |
B Buy |
| 16 | NSTG | NanoString Technologies, Inc. | 36.39 | 35.58 | 37.08 | 35.29 | 37.08 | 13.85 | 1.36 (3.88%) | 30.81% | 27.00% | 1.37B | 31.01 | 17.35% | 27.47 | 32.45% |
B Buy |
| 17 | HSKA | Heska Corporation | 92.14 | 94.23 | 94.23 | 90.35 | 110.90 | 50.00 | 0.09 (0.10%) | -3.96% | 13.46% | 865.38M | 82.69 | 11.43% | 84.21 | 9.42% |
B Buy |
| 18 | QTRX | Quanterix Corporation | 28.24 | 28.30 | 28.30 | 27.90 | 33.67 | 10.90 | 0.36 (1.29%) | 19.51% | -10.57% | 799.50M | 26.41 | 6.91% | 23.66 | 19.35% |
B Buy |
| 19 | SRDX | Surmodics, Inc. | 42.81 | 43.77 | 43.97 | 41.77 | 49.00 | 22.06 | -0.19 (-0.44%) | 3.33% | 4.42% | 582.47M | 38.99 | 9.80% | 39.09 | 9.53% |
B Buy |
| 20 | SMLR | Semler Scientific Inc. | 45.49 | 45.50 | 46.10 | 45.15 | 57.84 | 30.00 | 0.29 (0.64%) | -5.23% | 3.39% | 298.32M | 44.20 | 2.91% | 44.70 | 1.77% |
B Buy |
| 21 | IQV | IQVIA Holdings, Inc. | 143.45 | 143.22 | 144.00 | 140.87 | 169.14 | 81.79 | 1.92 (1.36%) | -7.16% | -10.83% | 27.39B | 140.26 | 2.27% | 142.01 | 1.01% |
C Neutral |
| 22 | LH | Laboratory Corporation of America Holdings | 171.11 | 172.62 | 173.98 | 171.11 | 196.36 | 98.02 | 0.84 (0.49%) | 1.15% | -3.09% | 16.63B | 168.56 | 1.51% | 165.81 | 3.20% |
C Neutral |
| 23 | EXAS | Exact Sciences Corporation | 88.82 | 87.66 | 89.31 | 87.50 | 123.99 | 35.25 | 2.16 (2.49%) | -3.96% | -24.48% | 13.32B | 84.15 | 5.55% | 83.80 | 5.99% |
C Neutral |
| 24 | BRKR | Bruker Corporation | 42.31 | 42.22 | 42.67 | 41.86 | 54.49 | 30.78 | 0.81 (1.95%) | -16.84% | -16.69% | 6.53B | 40.53 | 4.40% | 44.30 | -4.50% |
C Neutral |
| 25 | PRAH | PRA Health Sciences, Inc. | 97.02 | 96.32 | 97.96 | 95.28 | 113.32 | 58.67 | 1.97 (2.07%) | -12.71% | -1.20% | 6.18B | 95.89 | 1.17% | 98.05 | -1.05% |
C Neutral |
| 26 | SYNH | Syneos Health, Inc. - | 58.56 | 59.11 | 59.11 | 57.63 | 74.25 | 30.02 | 1.03 (1.79%) | -1.54% | 15.31% | 6.10B | 56.49 | 3.67% | 55.28 | 5.93% |
C Neutral |
| 27 | IRTC | iRhythm Technologies, Inc. | 113.02 | 114.58 | 115.46 | 112.66 | 136.55 | 56.24 | -0.48 (-0.42%) | 65.99% | 44.26% | 3.06B | 117.97 | -4.20% | 86.77 | 30.25% |
C Neutral |
| 28 | BEAT | BioTelemetry, Inc. | 46.61 | 46.63 | 46.96 | 46.14 | 55.85 | 27.35 | 1.05 (2.30%) | 0.67% | -4.84% | 1.59B | 45.94 | 1.47% | 44.55 | 4.63% |
C Neutral |
| 29 | AXDX | Accelerate Diagnostics, Inc. | 16.79 | 16.50 | 16.99 | 16.50 | 23.13 | 4.53 | 0.93 (5.86%) | -0.65% | -27.87% | 928.00M | 10.47 | 60.36% | 13.84 | 21.28% |
C Neutral |
| 30 | FLGT | Fulgent Genetics, Inc. | 18.35 | 16.60 | 18.45 | 16.50 | 20.60 | 5.62 | 2.14 (13.20%) | 42.25% | 187.33% | 398.16M | 16.28 | 12.72% | 13.59 | 34.98% |
C Neutral |
| 31 | OXFD | Oxford Immunotec Global PLC - Ordinary Shares | 13.17 | 13.25 | 13.25 | 12.99 | 17.77 | 8.37 | 0.09 (0.69%) | -20.66% | -4.77% | 341.71M | 12.50 | 5.40% | 14.15 | -6.94% |
C Neutral |
| 32 | LOGC | LogicBio Therapeutics, Inc. | 8.43 | 8.56 | 8.96 | 8.40 | 14.00 | 3.05 | 0.11 (1.32%) | 17.08% | -25.00% | 197.55M | 7.11 | 18.62% | 7.91 | 6.52% |
C Neutral |
| 33 | ONVO | Organovo Holdings, Inc. | 0.63 | 0.61 | 0.64 | 0.60 | 0.93 | 0.19 | 0.01 (1.65%) | 77.12% | 35.26% | 82.68M | 0.57 | 10.51% | 0.41 | 54.78% |
C Neutral |
| 34 | BASI | Bioanalytical Systems, Inc. | 5.02 | 5.23 | 5.23 | 5.00 | 6.50 | 1.95 | -0.22 (-4.20%) | 1.41% | 157.00% | 54.54M | 4.85 | 3.47% | 4.54 | 10.56% |
C Neutral |
| 35 | MYGN | Myriad Genetics, Inc. | 11.83 | 11.83 | 12.06 | 11.57 | 48.40 | 9.24 | 0.25 (2.16%) | -56.56% | -57.40% | 881.99M | 14.01 | -15.58% | 21.23 | -44.27% |
D Sell |
| 36 | RDNT | RadNet, Inc. | 15.46 | 16.24 | 16.24 | 15.46 | 23.45 | 5.81 | -0.37 (-2.34%) | -23.84% | 13.62% | 783.74M | 15.61 | -0.97% | 16.70 | -7.42% |
D Sell |
| 37 | PACB | Pacific Biosciences of California, Inc. | 3.88 | 3.78 | 3.89 | 3.78 | 6.13 | 2.20 | 0.14 (3.74%) | -24.51% | -36.42% | 598.73M | 3.55 | 9.34% | 4.24 | -8.58% |
D Sell |
| 38 | LNTH | Lantheus Holdings, Inc. | 14.56 | 14.77 | 14.78 | 14.33 | 29.04 | 8.67 | 0.00 (0.00%) | -29.01% | -48.89% | 578.85M | 13.43 | 8.38% | 16.90 | -13.85% |
D Sell |
| 39 | CO | Global Cord Blood Corporation | 3.03 | 3.01 | 3.08 | 2.81 | 5.92 | 2.54 | 0.04 (1.34%) | -39.40% | -46.59% | 368.30M | 2.88 | 5.16% | 4.04 | -25.02% |
D Sell |
| 40 | FLDM | Fluidigm Corporation | 4.48 | 4.74 | 4.94 | 4.47 | 12.26 | 1.17 | 0.00 (0.00%) | 28.74% | -61.00% | 316.76M | 3.95 | 13.33% | 3.52 | 27.35% |
D Sell |
| 41 | VNRX | VolitionRX Limited | 3.65 | 3.73 | 3.92 | 3.65 | 6.84 | 2.22 | 0.03 (0.83%) | -23.00% | 17.36% | 150.40M | 3.63 | 0.42% | 4.36 | -16.27% |
D Sell |
| 42 | ENZ | Enzo Biochem, Inc. ($0.01 Par Value) | 2.35 | 2.25 | 2.39 | 2.19 | 4.85 | 1.56 | 0.17 (7.80%) | -10.65% | -36.03% | 112.54M | 2.64 | -10.89% | 2.71 | -13.31% |
D Sell |
| 43 | OCX | OncoCyte Corporation | 1.30 | 1.59 | 1.59 | 1.22 | 3.51 | 1.22 | -0.25 (-16.13%) | -42.22% | -40.84% | 87.38M | 2.64 | -50.75% | 2.26 | -42.50% |
D Sell |
| 44 | SENS | Senseonics Holdings, Inc. | 0.38 | 0.38 | 0.39 | 0.36 | 1.87 | 0.36 | 0.00 (0.74%) | -58.52% | -79.50% | 86.48M | 0.48 | -20.09% | 0.84 | -54.78% |
D Sell |
| 45 | BIOC | Biocept, Inc. | 0.63 | 0.67 | 0.67 | 0.62 | 1.15 | 0.21 | -0.03 (-3.87%) | 120.28% | -39.03% | 82.74M | 0.52 | 21.87% | 0.48 | 29.93% |
D Sell |
| 46 | CEMI | Chembio Diagnostics, Inc. | 3.90 | 4.39 | 4.39 | 3.65 | 15.89 | 2.25 | -0.28 (-6.70%) | -14.47% | -31.92% | 78.66M | 9.18 | -57.50% | 6.15 | -36.60% |
D Sell |
| 47 | CELC | Celcuity Inc. | 7.37 | 7.25 | 7.58 | 7.25 | 24.02 | 4.03 | 0.30 (4.24%) | -30.73% | -67.73% | 75.72M | 7.55 | -2.36% | 10.15 | -27.42% |
D Sell |
| 48 | HTGM | HTG Molecular Diagnostics, Inc. | 0.61 | 0.61 | 0.64 | 0.61 | 1.64 | 0.27 | -0.04 (-5.51%) | -13.09% | -59.45% | 40.94M | 0.55 | 10.96% | 0.60 | 1.13% |
D Sell |
| 49 | PMD | Psychemedics Corporation | 5.57 | 5.75 | 5.79 | 5.36 | 10.69 | 4.54 | -0.22 (-3.80%) | -37.90% | -44.96% | 30.78M | 5.58 | -0.17% | 7.67 | -27.35% |
D Sell |
| 50 | OPGN | OpGen, Inc. | 2.02 | 2.03 | 2.05 | 2.01 | 12.80 | 0.92 | -0.05 (-2.42%) | 78.76% | -73.15% | 30.44M | 2.07 | -2.51% | 2.50 | -19.16% |
D Sell |
| 51 | GENE | Genetic Technologies Ltd representing 150 ordinary shares | 2.32 | 2.39 | 2.40 | 2.31 | 5.36 | 1.41 | -0.09 (-3.73%) | 16.58% | -10.22% | 19.77M | 2.15 | 7.97% | 2.37 | -2.00% |
D Sell |
| 52 | CGIX | Cancer Genetics, Inc. | 2.82 | 2.74 | 2.87 | 2.72 | 9.50 | 1.92 | 0.07 (2.55%) | -52.68% | -44.61% | 6.38M | 3.15 | -10.55% | 3.94 | -28.42% |
D Sell |
| NR | NRCIB | National Research Corporation | 53.01 | 51.95 | 53.37 | 50.38 | 58.16 | 40.27 | 4.97 (10.35%) | -5.44% | 32.56% | 1.30B | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | BRBR | BELLRING BRANDS, INC. | 19.70 | 19.59 | 20.12 | 19.35 | 24.03 | 13.56 | 0.39 (2.02%) | -7.47% | 20.79% | 776.73M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | CNTG | CENTOGENE N.V. | 24.00 | 25.76 | 25.84 | 23.50 | 28.71 | 7.80 | -0.50 (-2.04%) | 138.33% | 95.84% | 476.66M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | VRML | Vermillion, Inc. | 4.00 | 3.97 | 4.25 | 3.65 | 5.78 | 0.35 | -0.33 (-7.62%) | 393.83% | 247.83% | 389.51M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | XGN | EXAGEN INC. | 13.00 | 12.94 | 13.54 | 12.90 | 29.86 | 10.29 | 0.25 (1.96%) | -48.82% | -29.98% | 164.28M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | TROV | TrovaGene, Inc. | 1.19 | 1.19 | 1.19 | 1.16 | 3.46 | 0.70 | -0.01 (-0.83%) | -4.03% | -64.90% | 13.10M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
All price changes on this page include dividends and splits.